12/14/2023
5:02 AM | HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
8:00 AM | HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2023
8:54 AM | HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
2:49 PM | HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
OSMAN RONALD E (Reporting)
Ronald E Osman Irrevocable Trust III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
1:42 PM | HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
OSMAN RONALD E (Reporting)
Ronald E Osman Irrevocable Trust III (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2023
1:33 PM | HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
8:15 AM | HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/23/2023
11:49 AM | Black Robe Capital LLC (Filed by)
HedgePath Pharmaceuticals (Subject)
Inhibitor Therapeutics, Inc. (Subject)
| Form SC 13D | |
05/23/2023
11:38 AM | HedgePath Pharmaceuticals (Subject)
Inhibitor Therapeutics, Inc. (Subject)
TPB 2012 LLC (Filed by)
| Form SC 13G | |
05/22/2023
2:44 PM | Donovan James Joseph III (Reporting)
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
TPB 2012 LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/17/2023
6:46 PM | HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
MCNULTY JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
6:09 PM | HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
6:10 PM | Black Robe Capital LLC (Reporting)
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
MCNULTY JAMES A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/15/2023
8:00 AM | HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
